During the past decade, OptumCare Cancer Care at Fort Apache conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 55 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 44 clinical trials were completed. i.e. 129.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OptumCare Cancer Care at Fort Apache" #1 sponsor was "National Cancer Institute (NCI)" with 91 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "NRG Oncology" with 13 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OptumCare Cancer Care at Fort Apache" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "OptumCare Cancer Care at Fort Apache" are "Stage IV Lung Cancer AJCC v8" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Lung Non-Small Cell Carcinoma" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "OptumCare Cancer Care at Fort Apache" in a lesser frequency.

Most popular intervention types in "OptumCare Cancer Care at Fort Apache" are "Drug" (138 trials), "Other" (118 trials), "Biological" (78 trials), "Procedure" (54 trials) and "Radiation" (29 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (52 trials), "Laboratory Biomarker Analysis" (51 trials), "Computed Tomography" (33 trials), "Questionnaire Administration" (32 trials) and "Biospecimen Collection" (31 trials). Other intervention names were less common.

The vast majority of trials in "OptumCare Cancer Care at Fort Apache" are 156 trials for "All" genders, 19 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "OptumCare Cancer Care at Fort Apache". undefined are not yet recruiting, 56 are recruiting, 91 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in OptumCare Cancer Care at Fort Apache, 7 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in OptumCare Cancer Care at Fort Apache, 4 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".